Draft:Eidogen-Sertanty
Submission declined on 16 November 2023 by Ratnahastin (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has not been edited in over six months and qualifies to be deleted per CSD G13. Declined by Ratnahastin 13 months ago. Last edited by 76.90.121.176 12 months ago. Reviewer: Inform author.
|  |
| Submission declined on 16 November 2023 by Cabrils (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Cabrils 13 months ago.
| |
Comment: Well done on creating the draft, and it may potentially meet the relevant requirements (including WP:GNG, WP:NCORP) but presently it is not clear that it does. As you may know, Wikipedia's basic requirement for entry is that the subject is notable. Essentially subjects are presumed notable if they have received significant coverage in multiple published secondary sources that are reliable, intellectually independent of each other, and independent of the subject. To properly create such a draft page, please see the articles ‘Your First Article’, ‘Referencing for Beginners’ and ‘Easier Referencing for Beginners’. Also, if you have any connection to the subject, including being paid, you have a conflict of interest that you must declare on your Talk page (to see instructions on how to do this please click the link). Please familiarise yourself with these pages before amending the draft. If you feel you can meet these requirements, then please make the necessary amendments before resubmitting the page. It would help our volunteer reviewers by identifying, on the draft's talk page, the WP:THREE best sources that establish notability of the subject. You may also wish to leave a note for me on my talk page and I would be happy to reassess. Cabrils (talk) 02:57, 16 November 2023 (UTC)
 | |
| Industry | |
|---|---|
| Founded | 2003 |
| Founder | Steven Muskal (CEO) |
| Headquarters | , United States |
| Website | www |
Eidogen-Sertanty is an American software company founded in 2003. Eidogen-Sertanty provides software[1] and content[2] and engages in collaborative services[3] which accelerate the drug discovery process.
Databases
- Kinase Knowledgebase (KKB)[4] [5] - Database of kinase structure-activity data.
- Oncology Knowledgebase (OKB) - Database of oncological structure-activity data.
- Target Informatics Platform (TIP)[6] - Protein structural informatics system and knowledgebase.
Sertanty and Eidogen-Sertanty
In 2005, Sertanty acquired Eidogen and was renamed to Eidogen-Sertanty, Inc[7]
See also
References
- ^ Schürer, Stephan C.; Tyagi, Prashant; Muskal, Steven M. (1 March 2005). "Prospective Exploration of Synthetically Feasible, Medicinally Relevant Chemical Space". Journal of Chemical Information and Modeling. 45 (2): 239–248. doi:10.1021/ci0496853. PMID 15807484.Vidović, Dušica; Muskal, Steven M.; Schürer, Stephan C. (21 December 2012). "Novel Kinase Inhibitors by Reshuffling Ligand Functionalities Across the Human Kinome". Journal of Chemical Information and Modeling. 52 (12): 3107–3115. doi:10.1021/ci3003842. PMID 23121521.Muskal, Steven M.; Jha, Sanjiv Kumar; Kishore, M. Phani; Tyagi, Prashant (1 September 2003). "A Simple and Readily Integratable Approach to Toxicity Prediction". Journal of Chemical Information and Computer Sciences. 43 (5): 1673–1678. doi:10.1021/ci034080c. PMID 14502502.
- ^ "Chemical Information Sources/SIRCh/Cheminformatics/Companies and Independent Institutions - Wikibooks, open books for an open world". en.wikibooks.org.
- ^ Muskal, Steven M.; Sliman, Joe; Kokai-Kun, John; Pimentel, Mark; Wacher, Vince; Gottlieb, Klaus (22 June 2016). "Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway". F1000Research. 5: 606. doi:10.12688/f1000research.8406.3. PMC 4909102. PMID 27347377.Patel, Priya; Patel, Hiteshi; Vekariya, Dhara; Joshi, Chinmayi; Patel, Pooja; Muskal, Steven; Kothari, Vijay (5 July 2019). "Sonic Stimulation and Low Power Microwave Radiation Can Modulate Bacterial Virulence Towards Caenorhabditis elegans". Anti-Infective Agents. 17 (2): 150–162. doi:10.2174/2211352516666181102150049. S2CID 196993448.
- ^ Essegian, Derek J.; Chavez, Valery; Khurshid, Rabia; Merchan, Jaime R.; Schürer, Stephan C. (26 May 2023). "AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK". PLOS Computational Biology. 19 (5): e1010263. doi:10.1371/journal.pcbi.1010263.
{{cite journal}}: CS1 maint: unflagged free DOI (link) Sharma, Rajan; Schürer, Stephan C.; Muskal, Steven M. (2016-10-26). "High quality, small molecule-activity datasets for kinase research". F1000Research. 5: 1366. doi:10.12688/f1000research.8950.3. ISSN 2046-1402. PMC 4943296. PMID 27429748. Schürer, Stephan C.; Muskal, Steven M. (28 January 2013). "Kinome-wide Activity Modeling from Diverse Public High-Quality Data Sets". Journal of Chemical Information and Modeling. 53 (1): 27–38. doi:10.1021/ci300403k. PMC 3569091. PMID 23259810. Allen, Bryce K; Ayad, Nagi G; Schürer, Stephan C (2019-01-04). Kinome-wide activity classification of small molecules by deep learning (Report). Pharmacology and Toxicology. doi:10.1101/512459 - ^ Nicola, George; Kufareva, Irina; Ilatovskiy, Andrey V.; Abagyan, Ruben (March 2020). "Druggable exosites of the human kino-pocketome". Journal of Computer-Aided Molecular Design. 34 (3): 219–230. Bibcode:2020JCAMD..34..219N. doi:10.1007/s10822-019-00276-y. PMC 7082431. PMID 31925639.Wang, Huiwen; Qiu, Jiadi; Liu, Haoquan; Xu, Ying; Jia, Ya; Zhao, Yunjie (December 2019). "HKPocket: human kinase pocket database for drug design". BMC Bioinformatics. 20 (1): 617. doi:10.1186/s12859-019-3254-y. PMC 6884818. PMID 31783725.Jacoby, Edgar; Tresadern, Gary; Bembenek, Scott; Wroblowski, Berthold; Buyck, Christophe; Neefs, Jean-Marc; Rassokhin, Dmitrii; Poncelet, Alain; Hunt, Jeremy; van Vlijmen, Herman (June 2015). "Extending kinome coverage by analysis of kinase inhibitor broad profiling data". Drug Discovery Today. 20 (6): 652–658. doi:10.1016/j.drudis.2015.01.002. PMID 25596550.
- ^ Jacoby, Edgar (11 May 2006). Chemogenomics: Knowledge-based Approaches To Drug Discovery. World Scientific. ISBN 978-1-78326-009-6.
- ^ "Eidogen And Sertanty Inc. Complete Merger To Become Eidogen-Sertanty, Inc". BioSpace."Drug Discovery Software | Eidogen-Sertanty". eidogen-sertanty.com.
- in-depth (not just passing mentions about the subject)
- reliable
- secondary
- independent of the subject
Make sure you add references that meet these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.